The 12-month price targets, analyzed by analysts, offer insights with an average target of $508.38, a high estimate of ...

Sen. Bernie Sanders has been probing the high prices that Novo charges for Ozempic and Wegovy. Yesterday, he share that ...

The FDA should have more big news for Vertex only a few weeks later. It expects to announce an approval decision on ...

And we're really excited to have the Vertex IR team with us ... is a selective NaV1.8 channel inhibitor. So, we're stopping pain where it occurs in the peripheral neurons and because of that we don't ...

Ribometrix, a biotechnology company developing small molecule therapeutics that modulate RNA biology, presented the latest data from its eIF4E program at the European Society for Medical Oncology ...